Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Sahn

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
The New England Journal of Medicine|May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisTalmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2017
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice GuidelineNishant Gupta, Geraldine A Finlay, Robert M Kotloff, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2016
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and ManagementFrancis X McCormack, Nishant Gupta, Geraldine R Finlay, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Chest|April 10, 2015
Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary FibrosisDavid J Lederer, Williamson Z Bradford, Elizabeth A Fagan, et al.
The New England Journal of Medicine|May 20, 2014
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosisTalmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2017
Lymphangioleiomyomatosis Diagnosis and Management: High-Resolution Chest Computed Tomography, Transbronchial Lung Biopsy, and Pleural Disease Management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice GuidelineNishant Gupta, Geraldine A Finlay, Robert M Kotloff, et al.
American Journal of Respiratory and Critical Care Medicine|September 16, 2016
Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and ManagementFrancis X McCormack, Nishant Gupta, Geraldine R Finlay, et al.
Pageof 8